Elicio Therapeutics (ELTX) EBIT Margin (2020 - 2022)
Elicio Therapeutics (ELTX) reported EBIT Margin of 954.36% for Q2 2022, up 242415.0% on a YoY basis from N/an in Q2 2021, and down 8.58% quarter-over-quarter from 878.94% in Q1 2022.
Elicio Therapeutics (ELTX) EBIT Margin (2020 - 2022) Analysis & Trends
Elicio Therapeutics has reported EBIT Margin for 3 years, with the latest figure at 954.36% in Q2 2022.
- For the quarter ending Q2 2022, EBIT Margin rose 242415.0% year-over-year to 954.36%; the trailing twelve-month figure through Mar 2023 stood at 3946.09% (down 382848.0% YoY), and the FY2022 full-year result was 1031.42%, down 88852.0% from the prior year.
- EBIT Margin for Q2 2022 stood at 954.36%, down from 878.94% in the prior quarter.
- The five-year high for EBIT Margin was 621.63% in Q4 2020, with the low at 5374.39% in Q1 2021.
- Historically, EBIT Margin has averaged 1639.49% across 3 years, with a median of 1079.32% in 2021.
- Annual changes were most pronounced in 2021 — EBIT Margin sank 100966 bps — and 2022, when it jumped 449545 bps.
- Elicio Therapeutics' EBIT Margin stood at 621.63% in 2020, then tumbled by 91 bps to 58.22% in 2021, then sank by 1739 bps to 954.36% in 2022.
- The last three EBIT Margin figures came in at 954.36% (Q2 2022), 878.94% (Q1 2022), and 58.22% (Q4 2021), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -6.43% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 38.10% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Elicio Therapeutics | 70.12 Mn | 55.17 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | -954.36% |
| Mar 31, 2022 | -878.94% |
| Dec 31, 2021 | 58.22% |
| Sep 30, 2021 | -1,079.32% |
| Jun 30, 2021 | -3,378.52% |
| Mar 31, 2021 | -5,374.39% |
| Dec 31, 2020 | 621.63% |
| Sep 30, 2020 | -1,400.85% |
| Jun 30, 2020 | -2,368.86% |